In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity
- PMID: 3392362
- DOI: 10.1016/0091-6749(88)90059-0
In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity
Abstract
In vitro lymphocyte proliferation induced by carbamazepine (CBZ) was evaluated in nine patients with hypersensitivity to this drug. Lymphocytes from all hypersensitive patients responded by significantly enhanced DNA synthesis to CBZ when patients were compared with 33 tested control subjects. However, lymphocytes from five of six hypersensitive patients were not stimulated by carbamazepine-10, 11-epoxide, and oxcarbazepine (OXC), and this was confirmed clinically in two CBZ hypersensitive patients with OXC therapy. The results indicate that OXC may be suitable as an alternative therapy in some patients with CBZ hypersensitivity.
Similar articles
-
Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain.J Headache Pain. 2014 Jun 9;15(1):34. doi: 10.1186/1129-2377-15-34. J Headache Pain. 2014. PMID: 24912658 Free PMC article.
-
Allergy to carbamazepine: parallel in vivo and in vitro detection.Epilepsia. 1996 Nov;37(11):1093-9. doi: 10.1111/j.1528-1157.1996.tb01030.x. Epilepsia. 1996. PMID: 8917060
-
Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.Yonsei Med J. 2020 Oct;61(10):875-879. doi: 10.3349/ymj.2020.61.10.875. Yonsei Med J. 2020. PMID: 32975062 Free PMC article.
-
What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?Epilepsy Behav. 2004 Oct;5(5):627-35. doi: 10.1016/j.yebeh.2004.07.004. Epilepsy Behav. 2004. PMID: 15380112 Review.
-
Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.Eur J Neurol. 2016 Sep;23(9):1393-9. doi: 10.1111/ene.13069. Epub 2016 Jun 23. Eur J Neurol. 2016. PMID: 27333872 Review.
Cited by
-
Cellular in vitro diagnosis of adverse drug reactions.Allergo J Int. 2014;23(5):164-171. doi: 10.1007/s40629-014-0020-6. Epub 2014 Aug 7. Allergo J Int. 2014. PMID: 26120528 Free PMC article. Review.
-
Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.Drugs. 1992 Jun;43(6):873-88. doi: 10.2165/00003495-199243060-00007. Drugs. 1992. PMID: 1379159 Review.
-
Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.Br J Clin Pharmacol. 1992 Nov;34(5):377-95. doi: 10.1111/j.1365-2125.1992.tb05647.x. Br J Clin Pharmacol. 1992. PMID: 1467132 Free PMC article. Review. No abstract available.
-
In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.Mol Diagn Ther. 2009;13(5):313-30. doi: 10.1007/BF03256336. Mol Diagn Ther. 2009. PMID: 19791835
-
Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):472-6. doi: 10.1136/jnnp.52.4.472. J Neurol Neurosurg Psychiatry. 1989. PMID: 2738589 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical